|Human thyroid with cancer nodules|
|Classification and external resources|
Thyroid nodules are nodules (raised areas of tissue or fluid) which commonly arise within an otherwise normal thyroid gland. They may be hyperplasia or a thyroid neoplasm, but only a small percentage of the latter are thyroid cancers. Small, asymptomatic nodules are common, and many people who have them are unaware of them. But nodules that grow larger or produce symptoms may eventually need medical care. Goitres may have nodules or be diffuse.
- 1 Presentation
- 2 Diagnosis
- 3 Malignancy
- 4 Solitary thyroid nodule
- 5 Autonomous thyroid nodule
- 6 See also
- 7 References
Often these abnormal growths of thyroid tissue are located at the edge of the thyroid gland and can be felt as a lump in the throat. When they are large, they can sometimes be seen as a lump in the front of the neck.
Sometimes a thyroid nodule presents as a fluid-filled cavity called a thyroid cyst. Often, solid components are mixed with the fluid. Thyroid cysts most commonly result from degenerating thyroid adenomas, which are benign, but they occasionally contain malignant solid components.
After a nodule is found during a physical examination, a referral to an endocrinologist, a thyroidologist or otolaryngologist may occur. Most commonly an ultrasound is performed to confirm the presence of a nodule, and assess the status of the whole gland. Measurement of thyroid stimulating hormone and anti-thyroid antibodies will help decide if there is a functional thyroid disease such as Hashimoto's thyroiditis present, a known cause of a benign nodular goitre. Fine needle biopsy for histopathology is also used.
Thyroid nodules are extremely common in young adults and children. Almost 50% of people have had one, but they are usually only detected by a physician during the course of a health examination or fortuitously discovered during the investigation of an unrelated condition.
Ultrasound imaging is useful as the first-line, non-invasive investigation in determining the size, texture, position, and vascularity of a nodule, accessing lymph nodes metastasis in the neck, and for guiding fine needle aspiration cytology (FNAC) or biopsy. High frequency transducer (7–12 MHz) is used to scan the thyroid nodule, while taking cross-sectional and longitudinal sections during scan. Suspicious findings in a nodule are hypoechoic, ill-defined margins, absence of peripheral halo or irregular margin, fine, punctate microcalcifications, presence of solid nodule, high levels of irregular blood flow within the nodule or "taller-than-wide sign" (anterior-posterior diameter is greater than transverse diameter of a nodule). Features of benign lesion are: hyperechoic, having coarse, dysmorphic or curvilinear calcifications, comet tail artifact (reflection of a highly calcified object), absence of blood flow in the nodule, and presence of cystic (fluid-filled) nodule. However, the presence of solitary or multiple nodules is not a good predictor of malignancy. Malignancy is only diagnosed when ultrasound findings and FNAC report are suggestive of malignancy. Another imaging modality, which is ultrasound elastography, is also useful in diagnosing thyroid malignancy especially for follicular thyroid cancer. However, it is limited by the presence of adequate amount of normal tissue around the lesion, calcified shell around a nodule, cystic nodules, coalescent nodules.
Fine needle biopsy
Fine Needle Aspiration Cytology (FNAC) is a cheap, simple, and safe method in obtaining cytological specimens for diagnosis by using a needle and a syringe. The Bethesda System for Reporting Thyroid Cytopathology is the system used to report whether the thyroid cytological specimen is benign or malignant. It can be divided into six categories:
|Category||Description||Risk of malignancy||Recommendation|
|I||Non diagnostic/unsatisfactory||-||Repeating FNAC with ultrasound-guidance in more than 3 months|
|II||Benign (colloid and follicular cells)||0 - 3%||Clinical follow-up|
|III||Atypia of undetermined significance/follicular lesion of undetermined significance (follicular or lymphoid cells with atypical features)||5 - 15%||Repeating FNAC|
|IV||Follicular nodule/suspicious follicular nodule (cell crowding, micro follicles, dispersed isolated cells, scant colloid)||15 - 30%||Surgical lobectomy|
|V||Suspicious for malignancy||60 - 75%||Surgical lobectomy or near-total thyroidectomy|
|VI||Malignant||97 - 99%||Near-total thyroidectomy|
Repeated FNAC is recommended for Category I, followed by clinical follow-up in Category II, repeat FNAC for Category III, and lobectomy for Category IV, near total-thyroidectomy/lobectomy for Category V, and near total thyroidectomy for Category VI. The risk of malignancy in a malignant FNAC report is 93.7% while for suspicious FNAC report, it is 18.9%.
Blood tests may be done prior to or in lieu of a biopsy. The possibility of a nodule which secretes thyroid hormone (which is less likely to be cancer) or hypothyroidism is investigated by measuring thyroid stimulating hormone (TSH), and the thyroid hormones thyroxine (T4) and triiodothyronine (T3).
A thyroid scan using a radioactive iodine uptake test can be used in viewing the thyroid. A scan using iodine-123 showing a hot nodule, accompanied by a lower than normal TSH, is strong evidence that the nodule is not cancerous, as most hot nodules are benign.
Only a small percentage of lumps in the neck are malignant (around 4 – 6.5%), and most thyroid nodules are benign colloid nodules.
There are many factors to consider when diagnosing a malignant lump. Trouble swallowing or speaking, swollen cervical lymph nodes or a firm, immobile nodule are more indicative of malignancy, whereas a family history of autoimmune disease or goiter, thyroid hormonal dysfunction or a soft, painful nodule are more indicative of benignancy.
The prevalence of cancer is higher in males, patients under 20 years old or over 70 years old, and patients with a history of head and neck irradiation or a family history of thyroid cancer.
Solitary thyroid nodule
Risks for cancer
Solitary thyroid nodules are more common in females yet more worrisome in males. Other associations with neoplastic nodules are family history of thyroid cancer and prior radiation to the head and neck. Most common cause of solitary thyroid nodule is benign colloid nodules and second most common cause is follicular adenoma.
Radiation exposure to the head and neck may be for historic indications such as tonsillar and adenoid hypertrophy, "enlarged thymus", acne vulgaris, or current indications such as Hodgkin's lymphoma. Children living near the Chernobyl nuclear power plant during the catastrophe of 1986 have experienced a 60-fold increase in the incidence of thyroid cancer. Thyroid cancer arising in the background of radiation is often multifocal with a high incidence of lymph node metastasis and has a poor prognosis.
Signs and symptoms
Worrisome sign and symptoms include voice hoarseness, rapid increase in size, compressive symptoms (such as dyspnoea or dysphagia) and appearance of lymphadenopathy.
- TSH – A thyroid-stimulating hormone level should be obtained first. If it is suppressed, then the nodule is likely a hyperfunctioning (or "hot") nodule. These are rarely malignant.
- FNAC – fine needle aspiration cytology is the investigation of choice given a non-suppressed TSH.
- Imaging – Ultrasound and radioiodine scanning.
5% of nodules are hot. Malignancy is virtually non-existent in hot nodules.
Surgery (thyroidectomy) may be indicated in the following instances:
- Reaccumulation of the nodule despite 3–4 repeated FNACs
- Size in excess of 4 cm in some cases
- Compressive symptoms
- Signs of malignancy (vocal cord dysfunction, lymphadenopathy)
- Cytopathology that does not exclude thyroid cancer
An alternative using high intensity focused ultrasound or HIFU has recently proved its effectiveness in treating benign thyroid nodules. This method is noninvasive, without general anesthesia and is performed in an ambulatory setting. Ultrasound waves are focused and produce heat enabling to destroy thyroid nodules.
Focused ultrasounds have been used to treat other benign tumors, such as breast fibroadenomas and fibroid disease in the uterus.
Autonomous thyroid nodule
An autonomous thyroid nodule or "hot nodule" is one that has thyroid function independent of the homeostatic control of the HPT axis (hypothalamic–pituitary–thyroid axis). According to a 1993 article, such nodules need to be treated only when they become toxic; surgical excision (thyroidectomy), radioiodine therapy, or both may be used.
|Wikimedia Commons has media related to Thyroid nodule.|
- "New York Thyroid Center: Thyroid Nodules".
- Vanderpump, MP (2011), "The epidemiology of thyroid disease", Br Med Bull, 99 (1): 39–51, doi:10.1093/bmb/ldr030, PMID 21893493.
- "Symptoms and causes - Mayo Clinic". Mayo Clinic.
- Bennedbaek FN, Perrild H, Hegedüs L (1999). "Diagnosis and treatment of the solitary thyroid nodule. Results of a European survey". Clin. Endocrinol. 50 (3): 357–63. doi:10.1046/j.1365-2265.1999.00663.x. PMID 10435062.
- Ravetto C, Colombo L, Dottorini ME (2000). "Usefulness of fine-needle aspiration in the diagnosis of thyroid carcinoma: a retrospective study in 37,895 patients". Cancer. 90 (6): 357–63. doi:10.1002/1097-0142(20001225)90:6<357::AID-CNCR6>3.0.CO;2-4. PMID 11156519.
- "Thyroid Nodule".
- Russ G (Sep 2014). "Thyroid incidentalomas: epidemiology, risk stratification with ultrasound and workup". European Thyroid Journal. 3: 154–63. doi:10.1159/000365289. PMC . PMID 25538897.
- Wong KT, Ahuja AT (2005). "Ultrasound of thyroid cancer". Cancer Imaging. 5: 157–66. doi:10.1102/1470-7330.2005.0110. PMC . PMID 16361145.
- Diaz Soto, Gonzalo; Halperin, Irene; Squarcia, Mattia; Lomena, Francisco; Puig Domingo, Manuel (10 September 2010). "Update in thyroid imaging. The expanding world of thyroid imaging and its translation to clinical practice". Hormones. 9 (4): 287–298. PMID 21112859.
- Diana, S Dean; Hossein, Gharib. "Fine-Needle Aspiration Biopsy of the Thyroid Gland". Thyroid Disease Manager. Archived from the original on 12 July 2017. Retrieved 16 October 2017.
- Renuka, I. V.; Saila Bala, G.; Aparna, C.; Kumari, Ramana; Sumalatha, K. (December 2012). "The Bethesda System for Reporting Thyroid Cytopathology: Interpretation and Guidelines in Surgical Treatment". Indian Journal of Otolaryngology and Head & Neck Surgery. pp. 305–311. doi:10.1007/s12070-011-0289-4.
- Renuka, I.V; Saila Bala, G; Aparna, C; Kumari, R; Sumalatha, K (December 2012). "The Bethesda System for Reporting Thyroid Cytopathology: Interpretation and Guidelines in Surgical Treatment". Indian J Otolaryngol Head Neck Surg. 64 (4): 305–311. doi:10.1007/s12070-011-0289-4. PMC .
- Tee, Yoon Y; Lowe, Adrain J; Brand, Caroline A (November 2007). "Fine-Needle Aspiration May Miss a Third of All Malignancy in Palpable Thyroid Nodules". Annals of Surgery. 246 (5): 714–720. doi:10.1097/SLA.0b013e3180f61adc.
our study showed that the risk of malignancy of malignant FNA and suspicious FNA diagnosis is around 93.7% and 18.9%, respectively.
- MedlinePlus Encyclopedia Thyroid scan
- http://www.uptodate.com/contents/diagnostic-approach-to-and-treatment-of-thyroid-nodules?source=search_result&search=thyroid+nodule&selectedTitle=1%7E100[full citation needed]
- Thyroid Nodule at eMedicine
- Schwartz 7th/e page 1679,1678
- Ali, SZ; Cibas, ES (2016). "The Bethesda System for Reporting Thyroid Cytopathology II". Acta cytologica. 60 (5): 397–398. PMID 27788511.
- Grani, G; Calvanese, A; Carbotta, G; D'Alessandri, M; Nesca, A; Bianchini, M; Del Sordo, M; Fumarola, A (January 2013). "Intrinsic factors affecting adequacy of thyroid nodule fine-needle aspiration cytology". Clinical endocrinology. 78 (1): 141–4. PMID 22812685.
- Gates, Jeremy D.; Benavides, Linda C.; Shriver, Craig D.; Peoples, George E.; Stojadinovic, Alexander (2009). "Preoperative Thyroid Ultrasound In All Patients Undergoing Parathyroidectomy?". Journal of Surgical Research. 155 (2): 254–60. doi:10.1016/j.jss.2008.09.012. PMID 19482296.
- Robbins pathology 8ed page 767
- "Echotherapy: Thyroid nodules".
- Vigneri, R; et al. (1993), "[Physiopathology of the autonomous thyroid nodule]", Minerva Endocrinol, 18 (4): 143–145, PMID 8190053.